/**
 * ML INTEGRATION GUIDE FOR ALZHEIMER'S EARLY DETECTION SYSTEM
 * ==============================================================
 * 
 * CURRENT IMPLEMENTATION:
 * -----------------------
 * The current system uses rule-based NLP algorithms for analysis:
 * 
 * 1. Levenshtein Distance Algorithm
 *    - Calculates semantic similarity between original story and recall
 *    - Measures edit distance to determine how closely the recall matches
 * 
 * 2. Key Point Extraction
 *    - Identifies 14 critical story elements (names, objects, actions)
 *    - Tracks which elements are recalled vs. missed
 * 
 * 3. Coherence Scoring
 *    - Evaluates sentence structure and narrative flow
 *    - Checks for proper length and multi-sentence responses
 * 
 * 4. Multi-Factor Scoring
 *    - 40%: Key point retention
 *    - 30%: Semantic similarity
 *    - 30%: Coherence
 * 
 * 5. Risk Stratification
 *    - Categorizes into Low/Moderate/High risk based on thresholds
 *    - Considers both absolute scores and recall decay
 * 
 * 
 * RECOMMENDED ML ENHANCEMENTS:
 * ----------------------------
 * 
 * Phase 1: Advanced NLP Models
 * 
 * 1. Transformer-Based Semantic Analysis (BERT/RoBERTa)
 *    - Use pre-trained models for better semantic understanding
 *    - Implementation:
 *      ```
 *      import { pipeline } from '@xenova/transformers';
 *      const extractor = await pipeline('feature-extraction', 'sentence-transformers/all-MiniLM-L6-v2');
 *      const embeddings = await extractor(text);
 *      ```
 *    - Provides more nuanced similarity scoring than Levenshtein
 * 
 * 2. Named Entity Recognition (NER)
 *    - Better identification of key story elements
 *    - Automatically extracts people, places, objects, actions
 *    - Implementation with spaCy or Hugging Face models
 * 
 * 3. Sentiment & Emotional Analysis
 *    - Detect emotional content changes between recalls
 *    - May indicate confabulation or false memory insertion
 * 
 * 
 * Phase 2: Speech-to-Text Enhancement
 * 
 * 1. Advanced Speech Recognition (Whisper, Google Speech-to-Text)
 *    - More accurate transcription reduces analysis errors
 *    - Captures speech patterns like hesitations, pauses
 *    - Implementation:
 *      ```
 *      import { WhisperModel } from '@xenova/transformers';
 *      const model = await WhisperModel.from_pretrained('openai/whisper-tiny');
 *      const transcript = await model.transcribe(audioBlob);
 *      ```
 * 
 * 2. Prosody Analysis
 *    - Analyze speech rate, pitch variations, pauses
 *    - Important indicators of cognitive processing
 *    - Requires audio signal processing libraries
 * 
 * 
 * Phase 3: Custom ML Models
 * 
 * 1. Binary Classification Model
 *    - Train on validated clinical datasets (e.g., DementiaBank corpus)
 *    - Input features:
 *      * Word count, sentence count
 *      * Unique word ratio
 *      * Semantic coherence score
 *      * Key point recall percentage
 *      * Recall decay rate
 *      * Speech rate and pause patterns
 *    - Output: Risk probability (0-1)
 *    - Model architecture: Gradient Boosting (XGBoost) or Neural Network
 * 
 * 2. Time Series Analysis
 *    - Track changes over multiple assessments
 *    - Identify declining trends
 *    - LSTM or GRU networks for sequence modeling
 * 
 * 3. Multi-Task Learning
 *    - Simultaneously predict:
 *      * Alzheimer's risk
 *      * MCI (Mild Cognitive Impairment) likelihood
 *      * Cognitive domain deficits
 *    - Shared feature extraction with task-specific heads
 * 
 * 
 * Phase 4: Advanced Features
 * 
 * 1. Ensemble Methods
 *    - Combine multiple models for robust predictions
 *    - Rule-based + Transformer-based + Custom ML
 *    - Weighted voting or stacking
 * 
 * 2. Explainable AI (XAI)
 *    - LIME or SHAP for model interpretability
 *    - Show which features contributed to risk assessment
 *    - Critical for clinical trust and adoption
 * 
 * 3. Active Learning
 *    - Continuously improve with clinician feedback
 *    - Flag uncertain cases for expert review
 *    - Update model with validated results
 * 
 * 
 * RECOMMENDED DATASETS:
 * ---------------------
 * 
 * 1. DementiaBank Corpus (Pitt Corpus)
 *    - Cookie Theft picture description task
 *    - Gold standard for Alzheimer's speech research
 *    - Contains transcripts from healthy controls and AD patients
 * 
 * 2. ADReSS Challenge Dataset
 *    - Alzheimer's Dementia Recognition through Spontaneous Speech
 *    - Balanced dataset with audio and transcripts
 * 
 * 3. Framingham Heart Study Cognitive Data
 *    - Longitudinal cognitive assessment data
 * 
 * 
 * INTEGRATION EXAMPLE (BERT Similarity):
 * ---------------------------------------
 * 
 * ```typescript
 * import { pipeline } from '@xenova/transformers';
 * 
 * async function calculateSemanticSimilarity(
 *   originalStory: string,
 *   recalledStory: string
 * ): Promise<number> {
 *   const embedder = await pipeline(
 *     'feature-extraction',
 *     'sentence-transformers/all-MiniLM-L6-v2'
 *   );
 *   
 *   const [originalEmbedding] = await embedder(originalStory);
 *   const [recalledEmbedding] = await embedder(recalledStory);
 *   
 *   // Calculate cosine similarity
 *   const dotProduct = originalEmbedding.reduce(
 *     (sum: number, val: number, i: number) => 
 *       sum + val * recalledEmbedding[i],
 *     0
 *   );
 *   
 *   const magnitudeA = Math.sqrt(
 *     originalEmbedding.reduce((sum: number, val: number) => sum + val * val, 0)
 *   );
 *   const magnitudeB = Math.sqrt(
 *     recalledEmbedding.reduce((sum: number, val: number) => sum + val * val, 0)
 *   );
 *   
 *   const cosineSimilarity = dotProduct / (magnitudeA * magnitudeB);
 *   return cosineSimilarity * 100; // Convert to percentage
 * }
 * ```
 * 
 * 
 * PERFORMANCE METRICS TO TRACK:
 * ------------------------------
 * 
 * 1. Sensitivity (True Positive Rate)
 *    - Percentage of actual AD cases correctly identified
 *    - Target: >85% for screening tool
 * 
 * 2. Specificity (True Negative Rate)
 *    - Percentage of healthy individuals correctly identified
 *    - Target: >80% to minimize false alarms
 * 
 * 3. Area Under ROC Curve (AUC-ROC)
 *    - Overall model discrimination ability
 *    - Target: >0.90 for clinical deployment
 * 
 * 4. Positive Predictive Value (PPV)
 *    - Probability that positive prediction is correct
 *    - Depends on disease prevalence in population
 * 
 * 
 * ETHICAL & REGULATORY CONSIDERATIONS:
 * -------------------------------------
 * 
 * 1. FDA Clearance
 *    - If used for diagnosis: Class II medical device
 *    - Requires clinical validation studies
 * 
 * 2. HIPAA Compliance
 *    - Secure storage of PHI
 *    - Encrypted data transmission
 *    - Audit logging
 * 
 * 3. Bias Mitigation
 *    - Test across diverse populations
 *    - Account for education, language, cultural factors
 *    - Avoid algorithmic bias
 * 
 * 4. Transparency
 *    - Clear communication of limitations
 *    - Not a replacement for clinical diagnosis
 *    - Results should prompt professional consultation
 * 
 * 
 * NEXT STEPS FOR IMPLEMENTATION:
 * -------------------------------
 * 
 * 1. Short-term (1-3 months)
 *    - Integrate Transformers.js for BERT-based similarity
 *    - Improve speech-to-text with Whisper
 *    - Add more sophisticated coherence metrics
 * 
 * 2. Medium-term (3-6 months)
 *    - Collect pilot data with IRB approval
 *    - Train custom classification model
 *    - Implement explainable AI features
 * 
 * 3. Long-term (6-12 months)
 *    - Clinical validation study
 *    - Ensemble model deployment
 *    - Longitudinal tracking and trend analysis
 *    - Seek regulatory approval if applicable
 */

export const ML_INTEGRATION_STATUS = {
  currentApproach: "Rule-based NLP with Levenshtein distance",
  recommendedEnhancements: [
    "Transformer-based semantic analysis (BERT/RoBERTa)",
    "Advanced speech-to-text (Whisper)",
    "Custom ML classifier trained on clinical data",
    "Ensemble methods for robust predictions",
    "Explainable AI for clinical trust",
  ],
  readyForProduction: false,
  nextStep: "Integrate Transformers.js for semantic similarity",
};
